Autopsy report · NCT01605344

Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI

“Study was withdrawn due to lack of patient enrollment.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

UNC Lineberger Comprehensive Cancer Center

Sponsor type

University, hospital or other

Conditions

Advanced Adenocarcinoma of the Colon or Rectum

Interventions

FOLFIRI.; Atorvastatin

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Ozurdex Monotherapy Trial
  “The study was withdrawn due to insufficient participant enrollment.” (92% match in meaning)
• Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
  “Withdrawn: study halted prematurely, prior to enrollment of first participant” (84% match in meaning)
• BLOOM: Boldly Living outdOOrs for Mental Health
  “Study was withdrawn because available funding ended and could not be extended. No participants were enrolled.” (84% match in meaning)
• Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
  “The study was withdrawn due to lack of financial support.” (83% match in meaning)
• Hand Injected Ventriculography vs. Power Injected Left Ventriculography
  “Study was stopped due to low enrollment.” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.